{"product_id":"global-microbiomes-market-2023-2027","title":"Global Microbiomes Market 2023-2027","description":"\u003cp\u003eGlobal Microbiomes Market 2023-2027\u003c\/p\u003e\n\n\u003cp\u003eTechnavio has been monitoring the microbiomes market and it is poised to grow by $891.94 mn during 2022-2027, accelerating at a CAGR of 21.95% during the forecast period. Our report on the microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\u003c\/p\u003e\n\n\u003cp\u003eThe report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diseases, increasing initiatives and investments in microbiome research, and advances in microbiome discovery, therapeutics, and diagnostics.\u003c\/p\u003e\n\n\u003cp\u003eTechnavio's microbiomes market is segmented as below:\u003c\/p\u003e\n\n\u003cp\u003eBy ApplicationTherapeuticsDiagnosticsBy ProductProbioticsFoodsPrebioticsMedical foodOthersBy Geographical LandscapeNorth AmericaEuropeAsiaRest of World (ROW)This study identifies the significant number of collaborations for developing microbiome therapeutics as one of the prime reasons driving the microbiomes market growth during the next few years. Also, the growing focus on developing biosensors and genetic circuits and developments in regulatory framework will lead to sizable demand in the market.\u003c\/p\u003e\n\n\u003cp\u003eTechnavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the microbiomes market covers the following areas:Microbiomes market sizingMicrobiomes market forecastMicrobiomes market industry analysisTechnavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microbiomes market vendors that include 4D pharma Plc, AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc., and YSOPIA Bioscience. Also, the microbiomes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.\u003c\/p\u003e\n\n\u003cp\u003eThe study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.\u003c\/p\u003e \n\n\u003cp\u003eTechnavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ 157 Pages \/ MCW16225292","offer_id":47639646372146,"sku":null,"price":3000.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-microbiomes-market-2023-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}